Source: ERJ Open Res, 5 (1) 00115-2018; 10.1183/23120541.00115-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Margarida Correia-Neves, Gabrielle Fröberg, Liudmyla Korshun, Sofia Viegas, Paula Vaz, Nehaben Ramanlal, Judith Bruchfeld, Beston Hamasur, Patrick Brennan, Gunilla Källenius. Biomarkers for tuberculosis: the case for lipoarabinomannan. ERJ Open Res, 5 (1) 00115-2018; 10.1183/23120541.00115-2018

Member's Comments

No comment yet.

Related content which might interest you: Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis Source: Eur Respir J 2011; 38: 1398-1405 Year: 2011 LATE-BREAKING ABSTRACT: Intracellular ESAT-6: a new biomarker of mycobacterium tuberculosis infection? Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Witness of tuberculosis: lipoarabinomannan antigen Source: Eur Respir J 2004; 24: Suppl. 48, 34s Year: 2004 Identification of nontuberculous mycobacteria using GenoType® Mycobacterium CM Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of tuberculosis in HIV patients; Egyptian experience Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Usefulness of serum glycopeptidolipid core immunoglobulin A antibody in mycobacterium avium complex infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania Source: Eur Respir J 2015; 46: 761-770 Year: 2015 Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Evaluation of a IFN-γ test using Mycobacterium tuberculosis-specific antigens for diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006 Utility of quantitative analysis of urine lipoarabinomannan in the diagnosis of tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Pathogenicity of NTM: new developments Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 Beyond the IFN-? horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis Source: Eur Respir J 2014; 43: 1472-1486 Year: 2014 Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014